Showing 5801-5810 of 5956 results for "".
- University of Toledo Chemists Discover How Blue Light Speeds Blindnesshttps://modernod.com/news/university-of-toledo-chemists-discover-how-blue-light-speeds-blindness/2479929/Blue light from digital devices and the sun transforms vital molecules in the retina into cell killers, according to optical chemistry research at The University of Toledo. The process outlined in the study, which was recently published in the journal
- Roche’s Genentech Unit to Cut 223 Jobs in UShttps://modernod.com/news/roches-genentech-unit-to-cut-223-jobs-in-us/2479930/Roche’s Genentech unit plans to cut 223 jobs from its South San Francisco, California headquarters by the end of the year. The company, which disclosed the staff reductions in a Worker Adjustment and Retraining Notification (WARN) posted by the State of California’s Employment Develop
- Topcon Announces Date for 3rd Annual ISSOCT Conferencehttps://modernod.com/news/topcon-announces-date-for-3rd-annual-issoct-conference/2479931/Topcon Medical Systems has announced that the 3rd Annual ISSOCT Conference will be held on February 10-11, 2019 at the Sanibel Harbour Marriott Resort in Fort Myers, Florida. The world’s leading ophthalmologist
- FDA Approves 12-Week Dosing for Eylea in Wet AMD Patientshttps://modernod.com/news/fda-approves-12-week-dosing-for-eylea-in-wet-amd-patients/2479932/Regeneron announced that the FDA has approved a supplemental Biologics License Application for Eylea (aflibercept) injection in patients with wet age-related macular degeneration (AMD). The application was based on second-year data from the phase 3 VIEW 1 and 2 trials in which patients with wet A
- Mount Sinai Researchers Discover How to Restore Vision Using Retinal Stem Cellshttps://modernod.com/news/mount-sinai-researchers-discover-how-to-restore-vision-using-retinal-stem-cells/2479939/Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases
- Glasses May Boost Productivity for Rural Workershttps://modernod.com/news/glasses-may-boost-productivity-for-rural-workers/2479941/Providing reading glasses may be an inexpensive way to improve productivity, as well as earnings and quality of life, among workers in developing countries, suggests a clinical trial involving tea pickers in India, according to a Reuters Health
- Aerie Pharmaceuticals Reports Topline Results From Rhopressa Mechanism of Action Studyhttps://modernod.com/news/aerie-pharmaceuticals-reports-topline-result-from-rhopressa-mechanism-of-action-study/2479942/Aerie Pharmaceuticals announced topline efficacy results from a double-masked, randomized, placebo-controlled study designed to evaluate the effect of Rhopressa (netarsudil ophthalmic solution 0.02%) on aqueous humor dynamics in patients with open-angle glaucoma or ocular hypertension. While seve
- Breakthrough in AI Technology to Improve Care for Patientshttps://modernod.com/news/breakthrough-in-ai-technology-to-improve-care-for-patients/2479943/Two years ago, Moorfields Eye Hospital NHS Foundation Trust and DeepMind Health came together to announce a 5-year partnership to explore whether artificial intelligence (AI) technology could help clinicians improve care for patients. Researchers from Moorfields and the UCL Institute of Op
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmology for 17th Timehttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology-for-17th-time/2479945/U.S News & World Report has once again ranked Bascom Palmer Eye Institute of the University of Miami Health System as the nation’s best in ophthalmology. Recognized as a global leader in vision research, medical education and patient care, Basco
- Astellas Announces Acquisition of Quethera, Maker of Gene Therapy Program for Glaucomahttps://modernod.com/news/astellas-announces-acquisition-of-quethera-maker-of-gene-therapy-program-for-glaucoma/2479949/Astellas Pharma has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma. Under the terms of the agreement, Astellas may pay up to £85 million ($1